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Scientists have favorable opinions 
on immunity certificates but raise 
concerns regarding fairness 
and inequality
Iván Aranzales1,2, Ho Fai Chan1,2, Reiner Eichenberger3,4, Rainer Hegselmann5, 
David Stadelmann2,4,6,7* & Benno Torgler1,2,4
During the first wave of the COVID-19 pandemic, we collected over 12,000 responses from a survey of 
scientists, who were asked to express their opinions on immunity certificates (also called “immunity 
passports”) as a potential instrument to lessen the impact of the crisis. Overall, we find that scientists 
perceive immunity certificates as favorable for public health (50.2%) and the state of the economy 
(54.4%) while one-fifth (19.1%) and one-sixth (15.4%) disagree. Scientists stipulate some concerns 
about fairness (36.5%) and inequality (22.4%) arising from implementation of immunity certification. 
We find some smaller differences among scientific fields, particularly between health scientists 
and social scientists, with the latter being slightly more positive about the effect of immunity 
certification. Scholars in the United States, including health scientists, are more likely to view the 
immunity certificates favorably and mention fewer concerns about this policy’s effect on fairness and 
inequality. Female scholars are significantly less in favor of immunity certificates, while scientists 
with more conservative political views hold more favorable opinions. Our results reveal that given the 
uncertainties during an early phase of a pandemic, scientists see scope for immunity certification to 
lessen the general societal impacts of the crisis.
COVID-19-related uncertainty and policy reactions caused major disruptions in almost every country, with the 
US and several Western European nations experiencing high levels of infections and societal  fallouts1,2. With 
global eradication seen as unlikely, convalescent, and later vaccine induced immunity gained prominence as the 
path out of the crisis. In December 2020, the vaccine made by Pfizer and BioNTech became the first fully-tested 
immunization approved for emergency  use3 and developers of several vaccines announced excellent results. 
Insights are being generated over time through careful longitudinal studies on safety, immunogenicity, and 
protection  rate4. While the duration of vaccine-acquired immunity is yet uncertain, neutralizing antibodies after 
infection and induced immunological memory reactions to SARS-CoV-2 have been shown to persist for several 
months at  least5,6. As the number of people with convalescent-induced (infection induced) and vaccine-induced 
immunity continues to increase, the utility of strict infection control measures decreases. The economic and 
social costs of such measures were  high7.
Immunity certificates for convalescents were discussed by scientists early during the  pandemic8–11 and they 
received policy attention in several countries. Such certificates were mostly intended as a transitory tool to reduce 
the total costs of the  pandemic12; to allow individuals to resume their usual activities and interacting with others 
who were isolated or whose relationships were  interrupted13; and to facilitate travel, taking into account that 
immunity passports were already used in public health and travel  medicine14. While immunity certificates for 
convalescents were not introduced prior to the advent of vaccines, the introduction of Israel’s “Green Pass”—
intended for those vaccinated or those who have already contracted the disease—prompted a surge of calls 
from policy makers for implementation in early 2021. The President of the European Commission, Ursula von 
der Leyen, presented a legislative proposal for a type of European “Green Pass” that would include information 
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on whether there is proof that a person has been vaccinated, information on COVID19 recovery, or whether a 
person was tested for infection.
Acceptance of COVID-19 vaccines may differ among individuals. Existing evidence points to the usefulness 
of focusing on prosocial concerns when motivating vaccination  uptake15. A global survey assessing potential 
acceptance of a COVID-19 vaccine indicates country-level differences in acceptance rates ranging from less 
than 55% in Russia to 90% in  China16. Another study using European data reports that people’s willingness to 
vaccinate ranges from 30% (Hungary) to 80% (Denmark)17. Several individual-level differences are associated 
with the willingness to receive a  vaccine18. Organized campaigns by vaccine-hesitant groups promote beliefs that 
vaccinations are unsafe via social media, leading to vaccine hesitancy; a large proportion of the content shared 
about vaccines on popular social media sites are anti-vaccination  messages19. Thus, vaccine refusal is seen as a 
significant  problem17. Individual acceptance of vaccination may also be negatively affected by increasing immu-
nity levels in the population, as the incentive to free ride on others’ vaccinations  grows20,21. This raises the ques-
tion of whether immunity certificates would offer further motivation and positive incentive to vaccinate if they 
allow more individual freedom of movement and restoration of liberties, thereby empowering and motivating 
individuals to contribute to the common  good8. Enforced measures have been shown to crowd out voluntary 
support for COVID-19  policies22.
These considerations make the question of immunity certificates an ongoing and important policy topic in 
addressing the impacts of the COVID-19 crisis. An even more critical aspect may be whether immunity cer-
tificates could serve more generally as a policy instrument to reduce the costs of future pandemics, even when 
vaccine-induced immunity does not become available as quickly as it has during this pandemic. Seeking more 
clarity on the role of immunity certificates as a tool to mitigate some of the health, social, and economic impacts 
of pandemics, we conducted a survey of 12,738 scientists between May 4 and June 3, 2020. Early uncertainty 
about the duration and strength of convalescent immunity and the doubts regarding the potential of vaccine 
development make our survey interesting for understanding the scope of immunity certification in the initial 
stages of such a crisis. While future crises may be of a different structure, the knowledge that some immunity 
may be conferred by infection could make immunity certificates a helpful policy tool in specific circumstances.
Background and context
First and early evidence regarding the direct health effects of COVID-19 indicated that the high-risk group 
was largely comprised of elderly people and people with pre-existing medical  conditions23,24. In March 2020, 
the World Health Organization noted that most patients (80%) experienced mild illness, based on data from 
 China25. The number of asymptomatic cases was unknown but stated to be relevant for evaluation of policies 
and the ultimate severity of the  pandemic26.
Although evidence cannot exist for a new type of virus, the probability of contracting the same illness from 
the virus a second time within a few months or even years was considered to be small compared to a first occur-
rence of the illness. Numerous experts such as Peter Doherty—recipient of the Nobel Prize—suggested in media 
reports that even if there was a reinfection, prior infection would give an individual a level of immunity, allowing 
them to recover  quickly27. To some degree this was the—now seen as largely correct—prior belief.
Pandemics and the reactions to them increase the general problem of scarcity that always exists in society. The 
possible immunity of convalescents could make them each individually and as a group a valuable resource, and 
such resources multiply as the number of convalescents  increases12. Moreover, from a point of view of freedom, 
it is not easy to justify wide-ranging restrictions on this group of immune people. To make individual immunity 
useful during the crisis and for the individual, a certification that a person has contracted and recovered from 
COVID-19 would be vital. However, certification policies are connected with questions about individual freedom, 
public health, economic benefits, fairness, and inequality; all issues that were controversially discussed by the 
scientific  community9,10. In a statement on April 24, 2020 the World Health Orgazination suggested that “there 
is not enough evidence about the effectiveness of antibody-mediated immunity to guarantee the accuracy of 
an ‘immunity passport’ or ‘risk-free certificate’” and the organization stated that such certificates may increase 
the risks of  transmission28. Immunity certificates might create incentives for self-infection if they are associated 
with large benefits. Evidence on robust immune responses after infection accumulated over  time5,29,30, but with 
the advent of vaccines, widespread immunity came in reach at low risks. With vaccine availability in early 2021, 
Israel became the first country to introduce a “Green Pass” for vaccinated and previously infected individuals.
To evaluate opinions regarding immunity certificates as a policy tool, we designed a survey in late March and 
April 2020. The aim of the survey was to gather information on the acceptance of immunity certificates among 
scientists during a phase of uncertainty about the disease and uncertainty about the precise immune reactions, 
such that our conclusions could be useful when related discussions emerge during future crises. Data were col-
lected between May 4 and June 3, 2020; i.e., still during the first wave in most countries and where attention 
was heavily focused on COVID-19. Responses were gathered via the SurveyMonkey platform from scholars 
appearing in Scopus (see Method section). We also included scholars from the bibliographic database RePEc 
to increase the representation of social scientists (excluding these entries from the analysis does not influence 
our main conclusions, see Appendix SI). The design allowed us to collect the opinions of scientists across 37 
subfields and 63 countries (see Supplementary Fig. 1). We gathered a sample of 213,648 email addresses from 
journal publications. The response rate was 13.9% based on emails opened (see Supplementary Table 16) and 
12,738 scientists eventually concluded the survey. We aimed at a careful understanding and mapping of schol-
arly positions to establish the consensus of scientists’ opinions on different aspects of immunity certification. 
Survey respondents could skip any questions they did not want to answer. Ethical approval for the survey and 
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Humans are boundedly rational  beings31 and subject to  emotions32 such as fear. They react to the complexity 
of the  environment33, which affects their level of trust in the  government34. Limited information on contextual 
factors or dynamic changes may not allow for clear ideas about risks and facts in uncommon situations such as 
pandemics. The survey was addressed to scientists, and we explicitly address respondents in their function as 
a scientist. Being highly educated, being trained in rational thinking and dealing with aspects of uncertainty, 
scientists have the potential to represent an interesting group when exploring opinions regarding immunity cer-
tificates. Uncertainty is a core problem in pandemics, and historically pandemics have often caught governments 
and authorities unprepared and flat-footed, leading to confusion and  improvisation35. Scientists are also aware of 
how surveys work and deal daily with hypothetical situations. They are trained to think about social responsibil-
ity and therefore beyond personal interest, with a natural concern for understanding how people make choices. 
While they are not immune to bias and do not possess all information, they are usually better aware of the state 
of affairs than the wider public. Moreover, during crises they often inform policymakers and the public regarding 
scenarios, policy options, or potential trade-offs. In particular, governments can be heavily dependent on experts 
and scientific advice during crises due to their need for rapid  responses36. During pandemics such as COVID-19 
that represent a massive global health crisis, scientists can help policy-makers, leaders, decision-makers and the 
public in general to better understand how to handle and manage potential threats, how to find solutions, how 
to navigate different contexts (e.g., social or cultural), or how to align individual or collective interests while 
also providing effective science  communication37. Their attitudes towards policy tools can therefore shape how 
society copes with such crises. Policy-makers have a variety of tools available to deal with crises. It is therefore 
valuable to understand the acceptance of—and consensus on—available tools among scientists. Such an inquiry 
contributes to cognitive processes of learning to cope with new situations, feeding into the discussion process 
in which insights, attitudes, and preferences are exchanged. It provides a way of understanding not just existing 
knowledge but also values and priorities.
We informed the respondents in the survey by briefly introducing them to the idea of immunity certificates, 
stating: Suppose that there is enough evidence that suggests that people who were infected with COVID-19 and 
then recovered will likely be immune to re-infection for a certain period of time and are less likely to transmit the 
disease to others during this period. Authorities around the world may then consider policies for identifying people 
with immunity by using mass testing, assigning them “immunity certificates” (also called “immunity passports”) 
that officially declare them immune to COVID-19, and then employing them in critical positions on a voluntary 
basis (e.g., caring for the elderly). Much feedback on the questions suggested that the respondents were very well 
aware of the ongoing discussions on immunity certificates at the time of the survey.
Results
Overall attitudes towards immunity certificates. We asked scientists if they agree or disagree that 
immunity certificates are (1) good for public health; (2) good for the economy; (3) fair to others who do not have 
immunity; and (4) whether certification increases inequality (7-point scale from 1 (strongly disagree) to 7 
(strongly agree)). The survey results are provided in Fig. 1A. About half of scientists agree that issuance of immu-
nity certificates for the duration of immunity is good for public health (50.2%) and the economy (54.4%), while 
one-fifth (19.1%) and one-sixth (15.4%) disagree, respectively. In terms of fairness, about 36.5% of scholars think 
that issuing immunity certificates will not be fair to those who do not have immunity. 45.5% of the respondents 
think that immunity certificates will increase inequality in society.
To address the fear expressed by the World Health Organization that immunity certificates could increase 
transmission, we also confronted scholars with the following two scenarios: “Suppose that you were medically 
assessed to be in a low-risk group (high-risk group) and you are offered the possibility of receiving an immunity 
certificate for 12 months through intentional coronavirus self-infection. Further suppose that among every 1000 
infected people in the low-risk group (high-risk group), 1 person (50 people) dies (die) due to the coronavirus. 
How willing would you be to self-infect if the immunity certificate allowed for (a) lifting of social-isolation restric-
tions for the certificate holders, and (b) lifting of all restrictions and resumption of local and international travel. 
Willingness to self-infect is generally low in both scenarios (Fig. 1B). Overall, in the hypothetical low-risk sce-
nario, 56.1–58.4% of respondents indicated that they are not likely (< neutral preference) to self-infect to receive 
an immunity certificate. Further, about 71% of participants say they will be unlikely to self-infect if they were 
part of the high-risk group. It is only reasonable to expect that the probability of self-infection to obtain immu-
nity certification is now even lower given the existence of vaccines. Vaccination is associated with substantially 
smaller health risks than self-infection even for low-risk groups. We also asked scientists the maximum amount 
(in US$) they would be willing to pay for the opportunity to have an immunity certificate {$0, $100, $200, $500, 
$1000, more than $1000} (Fig. 1C). Most scientists (38.2% and 44.3%) reported they would not pay to obtain 
an immunity certificate. It is important to note that such a direct question measures hypothetical, rather than 
actual, willingness to pay; thereby generating a hypothetical bias. However, applying a more indirect approach 
would have had the disadvantage of overloading the survey.
Field comparisons. To explore differences across fields with respect to opinions about immunity certifi-
cates, we  follow38 in classifying fields into five groups: Natural Sciences (n = 1710), Applied Sciences (n = 829), 
Economic & Social Sciences (n = 4901), Health Sciences (n = 4851), and Arts & Humanities (n = 295). The distri-
butional differences across fields are reported in the Supplementary Information (see Supplementary Fig. 2 to 5 
and Supplementary Table 1). Our results indicate that Health Scientists are slightly more skeptical about whether 
immunity certificates are good for public health, particularly relative to scholars in the area of Applied Sciences 
(Cohen’s d = 0.075, p = 0.041) and Economic & Social Sciences (d = 0.076, p = 0.006), though the absolute differ-
ences are relatively small. Economists and Social Scientists are also more in favor of immunity certificates than 
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Figure 1.  Scientists’ attitudes towards immunity certificates. N = 12,738 participants. (A) Distribution 
of responses to the statements “Is giving immune people immunity certificates for the duration of their 
immunity…” regarding (1) good for public health; (2) good for the economy; (3) fair to others who do not have 
immunity; and (4) increasing inequality. Share of respondents who did not answer ranges from 15.3 to 15.9%. 
(B) Willingness to self-infect for immunity certificate that lifts social-isolation and travel restrictions, if medically 
assessed as low-risk or high-risk groups. (C) Willingness to pay for immunity certificate that lifts social-isolation 
and travel restrictions. Share of respondents who did not answer ranges from 18.2 to 18.9%.
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scholars in Arts & Humanities. The differences between Economics and Social Sciences and Health Scientists 
also small but visible when evaluating the economic benefit of immunity certificates (d = 0.06, p = 0.067). This 
does not come as a surprise, given that many of the economic advantages of immunity certificates suggested in 
the academic discussion were raised by Economists and Social Scientists early in the pandemic (see, e.g., 12). 
These scholars argue for viewing immune people as a vital resource that can be employed effectively to reduce 
the economic burden to society and promote the return to normality sooner, which will reduce secondary soci-
etal side effects caused by the pandemic. In the political discussion, economists have strongly emphasized the 
importance of putting numbers on the economic costs of shutdowns. For example, Kip Viscusi—an economist 
specializing in the economics of risk and uncertainty—argued in a New York Times article that “[m]aking peo-
ple poorer has health consequences as well” and that “[j]obless people sometimes commit suicide, and poor 
people are more likely to die if they become sick, estimating that every loss of $100 million in income from the 
economy causes one additional death”. Health scientists are somewhat more concerned about the fairness con-
siderations of immunity certificates (again, there are statistically significant differences between scholars from 
the fields of Applied Sciences (d = 0.093, p = 0.007) and Economics and Social Sciences (d = 0.095, p = 0.0002)). In 
an article for The Lancet, Alexandra Phelan—a health scientist at the Center for Global Health Science at George-
town University Medical Center—is critical that the administration of immunity certificates would be subject 
to corruption and implicit biases that will then be reflected in existing socioeconomic, racial, and ethical ineq-
uities, thereby exacerbating the harm inflicted to vulnerable  populations11. In addition, immunity certificates 
would risk enshrining discrimination and undermining the right to health of individuals and the population 
through perverse incentives. In June 2020, the Nuffield Council of Bioethics published a rapid policy briefing 
stating that “immunity certification raises many ethical questions concerning respect for individual rights and 
interests, public health responsibilities, and social justice”. For example, the report stressed that “An immune 
certified workforce may offer businesses a commercial or reputational advantage over competitors. Pursuing 
these incentives could lead to major social upheaval (as seronegative employees potentially lose opportunities 
to seropositive colleagues or applicants) and create coercive and stigmatising work environments”. On the other 
hand, in a more recent  article39, a group of health scholars argue that the “strength of much of this opposition 
does not seem justified by the strength of the arguments opposing immunity passports”8, (p. 3), stating that “[i]
mmunity passports are a potentially valuable and ethical tool” (p. 4). Interestingly, when looking at the opinions 
on increasing inequality, no statistically significant differences are found between fields. Overall, respondents in 
our sample share similar opinions regarding immunity certificates: they are generally evaluated as rather benefi-
cial from the public health and the economic perspective. Participants have some reservations regarding fairness 
and worry even slightly more about inequality.
When exploring the maximum amount (in US$) scientists would be willing to pay for the opportunity to have 
an immunity certificate that allows a) lifting social-isolation restrictions for the certificate holders and b) lifting 
all restrictions and resumption of local and international travel for the certificate holders (Supplementary Fig. 6 
and Supplementary Table 2), Economists and Social Scientists report a somewhat higher willingness to pay; a 
result that is statistically significant relative to scholars in Applied Sciences (d = 0.19−0.121, p < 0.001), Health 
Sciences (d = 0.16–0.176 p < 0.001), and Natural Sciences (d = 0.13–0.134, p < 0.001). On the other hand, whilst 
there is no statistically significant difference between willingness to self-infect to receive immunity certificates in 
the low-risk scenario (with the exception between Economics & Social Sciences and Health Sciences, d = 0.062, 
p = 0.031), some field differences emerge in the high-risk scenario (see Supplementary Fig. 7 and Supplementary 
Table 3). Applied Scientists (followed by Economists and Social Scientists) were more willing to self-infect to 
receive immunity certificates (statistically significant relative to all other groups), and Health Scientists are least 
likely to self-infect to obtain immunity certificates.
Differences between US and non-US scholars. We take a closer look at whether we observe differ-
ences in opinions between US and Non-US scholars, and indeed, we find appreciable disparities (see Fig.  2 
and Supplementary Table 4). Our data consists of a large number of US scholars (N = 4076, Applied Sciences: 
n = 169; Arts & Humanities: n = 102; Economics and Social Sciences: n = 1450; Health Sciences: n = 1937; Natural 
Sciences: n = 418). US scholars are significantly more in favor of immunity certificates when considering their 
relevance for public health (d = − 0.117, p < 0.001) and the economy (d = − 0.113, p < 0.001) (Fig. 2A). In general, 
Non-US scientists regard immunity certificates as more unfair to others (d = − 0.037, p < 0.001) and more likely 
to increase inequality (d = 0.053, p < 0.001), relative to their US-based counterparts; however, these effect sizes 
are small. Nevertheless, US scientists are less willing to self-infect when in a low-risk (d = 0.048–0.07, p < 0.01) 
and high-risk group (d = 0.195–0.189, p < 0.001), regardless of the type of restrictions the immunity certificate 
could lift (Fig. 2B). Regarding willingness to pay, US scholars show a higher willingness to pay for immunity 
certificates, question a) M = 249.49 (SD = 426.37) for US versus M = 149.33 (SD = 322.27) for Non-US (d = − 0.25, 
p < 0.001); question b) M = 302.18 (SD = 462.38) for US versus M = 213.53 (SD = 382.43) for Non-US (d = − 0.188, 
p < 0.001) (Fig. 2C).
Comparing US and Non-US scholars within fields (Supplementary Fig. 8 to 10 and Supplementary Table 5), 
both the US Health Sciences scholars and the US Economists and Social Scientists are more positive towards 
immunity certificates as something that is good for public health (d = − 0.193, p < 0.001 and d = − 0.069, p = 0.0278) 
and good for the economy (d = − 0.198, p < 0.001 and d = − 0.068, p = 0.029) (Supplementary Fig. 8). US Health 
Scientists have fewer fairness concerns with respect to immunity certificates (d = − 0.083, p = 0.007) and are less 
likely to view immunity certificates as increasing inequality (d = 0.090, p = 0.004). US and non-US differences in 
willingness to pay for an immunity certificate are evident in almost all fields, with the largest discrepancy among 
Natural Scientists (d = − 0.320–− 0.343, p < 0.001) (Supplementary Fig. 9). In terms of willingness to acquire an 
immunity certificate through self-infection, US Health Scientists hold stronger opposing views compared to their 
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Figure 2.  Difference in views on immunity certificates between US and non-US based scientists. (A) Views 
regarding perceived benefits to public health and economy, fairness, and societal inequality of immunity 
certificate. (B) Willingness to self-infect for immunity certificate that lifts social-isolation and travel restrictions. 
(C) Willingness to pay for immunity certificate that lifts social-isolation and travel restrictions. Two-sample 
mean comparison with t-test (two-tailed). Error bars represent 95% confidence intervals. Significance levels: 
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non-US counterparts in all four scenarios (low- or high-risk groups and whether immunity certificate would 
mean lifting social-isolation and travel restrictions; d = − 0.075–− 0.206, all p < 0.05). Nevertheless, while US 
scientists in other fields are also less willing to self-infect to receive an immunity passport (relative to non-US 
scientists in the same field) when they were in the hypothetical high-risk group, said differences were less visible 
in the low-risk scenario (Supplementary Fig. 10).
Consensus. Employing an entropy-based consensus measure, we observe that scholars show a higher level of 
consensus on the questions around favoring immunity certificates for public health (C = 0.578) and the economy 
(C = 0.606) compared with the questions around fairness (C = 0.535) and inequality (C = 0.538) (Fig. 3A). The 
latter questions are discussed from an ethical perspective in both academic and non-academic channels which 
may explain lower levels of consensus. Looking at the consensus within each field (Supplementary Fig. 11), Eco-
nomics and Social Sciences and Health Sciences tend to report higher levels of consensus. However, when closely 
examining whether field differences are statistically significant with Bonferroni adjustments, only the fairness 
and inequality questions lead to statistically significant field differences (Supplementary Table 6). Natural Sci-
entists indicate the lowest levels of consensus within their field and the differences are statistically significant in 
comparison to Health Scientists (p = 0.090) for fairness; and Health Sciences (p < 0.001), and Economics & Social 
Sciences (p = 0.063) for inequality.
Overall, consensus on the willingness to pay (C = 0.600–0.674) for an immunity passport is quite high 
(Fig. 3B). Economists report the lowest levels of consensus on the willingness to pay for an immunity passport 
(significantly lower than Health Sciences, Natural Sciences, and Applied Sciences) (Supplementary Fig. 12A 
and Supplementary Table 7). The lowest level of consensus among all questions is on the issue of self-infection 
with the low-risk scenario (Fig. 3C; C = 0.495–0.519); there are no significant differences between fields on the 
low-risk scenario (Supplementary Fig. 12B and Supplementary Table 7). On the other hand, consensus is high 
Figure 3.  Consensus among scientists. The entropy-based consensus measure takes the value of 1 when all 
responses are concentrated on one option and value of 0 when responses are evenly distributed in each available 
option. (A) Views on perceived benefits to public health and economy, fairness, and societal inequality of 
immunity certificates. (B) Willingness to pay for an immunity certificate that lifts social-isolation and travel 
restrictions. (C) Willingness to self-infect for an immunity certificate that lifts social-isolation and travel 
restrictions. Error bars represent 95% confidence intervals obtained from bootstrap resampling with 300 
replications. Null responses are excluded from the calculation of consensus.
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for the high-risk scenario (C = 0.668–0.671), with Health Scientists reporting a significantly higher level of 
consensus than do Economists and Social Scientists (p = 0.013 and p = 0.0057), Natural Scientists (p = 0.027 for 
lifting social-isolation restrictions) or Applied Scientists (p = 0.0021 and p = 0.0022).
US scholars demonstrate higher levels of consensus than non-US scholars across all questions (Supplementary 
Fig. 13 and Supplementary Table 8), except for those regarding willingness to pay, where consensus is lower for 
US scientists. The differences are statistically significant for all the questions. In the comparison of US and non-
US scholars within fields (Supplementary Fig. 14 to 15 and Supplementary Table 9), again, US scholars tend to 
show a higher level of consensus, except for willingness-to-pay questions. However, key differences are found 
within Economics and Social Science and Health Sciences on scientists’ perceptions that immunity passports are 
good for public health (p = 0.0072 and p < 0.001, respectively) and good for the economy (p = 0.014 and p < 0.001, 
respectively), and among Health Sciences with respect to fairness to others (p = 0.048). Some field differences 
are also found for willingness to pay, and self-infection in the high-risk scenario (statistically significant dif-
ferences for Economics and Social Sciences, Health Sciences, and Natural Sciences). Consensus is also higher 
among US Health Scientists (relative to Health Scientists elsewhere) in relation to willingness to self-infect in 
the low-risk scenario.
Political views. We explore the relevance of political views in greater detail (Fig.  4 and Supplementary 
Table 10 and 11) by running a set of ordered logit regressions. Scientists who hold more conservative views 
(more right-wing) are significantly more in favor of immunity certificates. They evaluate them as good for pub-
lic health (Odds Ratios 1.044, p = 0.023), good for the economy (OR 1.038, p = 0.052), fair to others (OR 1.130, 
p < 0.001) and do not see them as potentially increasing inequality (OR 0.893, p < 0.001). Their willingness to pay 
is higher (OR 1.071–1.073, p < 0.001), as is their willingness to self-infect to receive immunity certificates (Low-
risk scenario: OR 1.156, p < 0.001; High- risk scenario: OR 1.178–1.206, p < 0.001). This holds while accounting 
for individual characteristics, confirmed COVID-19 cases, case fatality rate, stringency index and different fixed 
effects.9 classify and reject arguments for immunity certificates as belonging to a conservative political view 
by highlighting the relevance of liberal individualism. They frame their own political rejection of immunity 
certificates as part of a communitarian approach to public health in line with progressive views.40 responded 
by stressing that “liberties should be restored to immune individuals precisely because they are not anymore a 
threat to the greater good”.
Individual differences. The results from the ordered logit regressions revealed individual differences in 
scientists’ attitudes toward immunity certification. Clear patterns are observed throughout all questions. Women 
scholars are significantly less likely to favor immunity certificates (estimates are statistically significant at 0.1% 
level for all ten dependent variables) even when accounting for other characteristics, political views, and contex-
tual factors, such as case and fatality rates as well as the stringency implementations. Interestingly, a recent study 
also indicates that women are more likely to perceive COVID-19 as a very serious health issue and more likely 
to favor using restrictive public policy measures, a difference that is considerable in all eight OECD countries 
 explored41. Controlling for academic rank, younger scholars (age group 18–29) tend to be more supportive of 
immunity certificates in terms of their benefit for public health (OR 1.24, p = 0.026) and the economy (OR 1.31, 
p = 0.009) compared to the baseline age  group30–39, while scientists above 40 showed less agreement regarding 
the economic benefit (p < 0.001 for all age groups above 40). Scientists in the age group > 50 demonstrated sub-
stantially more support for immunity passports with respect to fairness and inequality (relative to the age group 
30–39, p < 0.001 for all age groups above 50). Nevertheless, scientists with full professorship showed more sup-
port (compared to assistant professor or below) in terms of economic benefit (OR 1.149, p = 0.026) and inequal-
ity concerns (OR 0.83, p = 0.003). More senior ranked academics (full professorship) also expressed higher will-
ingness to pay (OR 1.716–1.723, p < 0.001) and self-infect for immunity certificates (OR 1.268–1.362, p < 0.001), 
while older age groups are less willing to pay for immunity certificates. Age groups 40–49 and 50–59 report a 
weak inclination to self-infect in both scenarios. One should note that the correlation between academic rank 
and age is high (0.605, p < 0.001); in an unreported analysis without controlling for academic rank, scientists in 
the older age group (60+) expressed more favorable views towards immunity certificates (the estimated odds 
ratios are above 1 for the fairness, willingness to pay, and willingness to self-infect questions and less than 1 for 
inequality concerns).
Married scientists (relative to those who are not in a relationship) are more supportive of the concept of 
immunity certificates for its perceived benefit for the economy (OR 1.216, p = 0.007) but less willing to self-infect 
to receive one (p < 0.001; this also holds for those in a de facto partnered relationship). Non-religious scientists 
(who never attend religious services) are more supportive of immunity certificates due to the potential benefit 
but are less inclined to self-infect. There is a tendency for those who believe it will take longer to get back to 
normality to answer in favor of immunity certificates for promoting public health and the economy. Scientists 
who imagine better prospects of returning to normality sooner have a lower willingness to pay but a higher 
willingness to self-infect to obtain an immunity certificate. Further analyses on the difference in prospect of 
returning to normal are given in Appendix SI (see ‘Return-to-normality timeline’).
Discussion
This study is the first to explore scientists’ attitudes and opinions regarding immunity certification. As an innova-
tive contribution, we present results based on our large-scale survey conducted among 12,738 scientists from 37 
subfields and 63 countries, with 4076 respondents from the US alone. Immunity certificates were an early topic 
of contention in this pandemic, but may serve as a policy tool in the future. Vaccination certificates are com-
monly used for vaccine induced immunity. During early phases of pandemics when no vaccines are available, 
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Figure 4.  Ordered logit regressions. Presented are odd ratios of covariates from 10 ordered logit regressions for 
(A) perceived benefits to public health and the economy, and fairness and inequality concerns and (B) willingness 
to pay and willingness to self-infect for immunity certificate. Error bars represent 95% confidence intervals. Full 
regression results are presented in Supplementary Table 10 for (A) and Supplementary Table 11 for (B).
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immunity certificates might be a policy tool to reduce the economic and societal burden of the pandemic. From 
a perspective of individual freedom, it is difficult to justify severe restrictions for convalescents.
As our survey on scientists’ perceptions of immunity certificates was conducted when vaccinations were not 
yet available, our results can be interpreted as a conservative threshold on the acceptance of vaccination-induced 
immunity and corresponding certification. Several arguments put forward by scholars against immunity certifi-
cates for convalescents are also applicable to vaccine-induced immunity; thus, the same scholars may object to 
any reduction of restrictions for vaccinated individuals until herd immunity is  achieved40, even though models 
have failed to support achieving herd immunity as a practical  objective42. Due to the uniform and controlled 
nature of treatment, the response of a vaccine-induced immunity is more predictable.
Our results indicate that Scientists tend to have favorable opinions on immunity certificates but raise some 
doubts regarding fairness and inequality. Comparing different fields suggests that Health Scientists are slightly 
less in favor of immunity certification, while Economists and Social Scientists tend to be supportive. US scientists 
tend to be more in favor of immunity passports even after controlling for many factors including contextual 
aspects such as the number of COVID-19 cases or deaths. A similar result is also found for Health Scientists.
There is less consensus among scientists on the questions of fairness and inequality. Scholars from fields that 
are more active in the policy discussion process report higher levels of consensus; in particular, Health Scientists 
report high consensus values in relative terms. Self-infection in a low-risk scenario produced less agreement 
compared with other questions. In addition, US scholars report a higher level of consensus than non-US scholars. 
Political views matter for support of immunity certificates—with scientists holding conservative views being 
more in favor. When exploring individual differences, we found that women are less supportive of immunity 
certificates. Young people also tend to care more about the immunity value in terms of economic benefit.
While many scholars are concerned about the effects of immunity certification on fairness and inequality, 
there will be a lag in vaccine-induced protection for countries that are particularly vulnerable to prolonged 
lockdowns but in which many convalescents might be found due to their comparatively young populations. 
The perceived benefits of immunity passports are likely to increase the longer it takes to bring back normality. 
Besides understanding the opinions of single scholars who hold the microphone in scientific outlets, it is worth 
mapping—as we have done—the opinions of a large number of scholars from different fields, and analyzing how 
individual differences shape the scholars’ opinions. Such mapping contributes to the important debate regarding 
which policy responses society should follow when coping with pandemics in the future.
Methods
Data. We conducted an online survey via the SurveyMonkey platform with scholars who have served as the 
corresponding author of an article published in the top-ranked journals in 55 scientific fields in the last five 
years (from 2015 to beginning of 2020). Journals were selected based on their 2019 SCImago Journal Ranking 
(SJR) in the 55 subject categories from 13 scientific areas defined by Scopus (Arts and Humanities; Business, 
Management and Accounting; Economics, Econometrics and Finance; Energy; Health Professions; Immunology 
and Microbiology; Medicine; Multidisciplinary; Neuroscience; Nursing; Pharmacology, Toxicology and Pharma-
ceutics; Psychology; Social Sciences). A total of 849 journals were sampled (see Dataset S1 in Appendix SI). We 
extracted the e-mail address of the corresponding authors from the journal publication records downloaded 
from the Scopus citation database when available (a total of 318,251 e-mail addresses were extracted). As numer-
ous social scientists and economists have highlighted the costs and trade-offs of the pandemic for society and 
the  economy37, we think it is important to oversample social scientists. For example, based on the COVID-19 
publication records dataset from Dimensions (as of 5 June 2021), economics and social sciences publications 
account for 47.5% of all non-health sciences COVID-19-related studies. Therefore, we also included scholars 
registered in the bibliographic database RePEc (https:// econp apers. repec. org/ RAS/) in our sample pool (addi-
tion of 68,470 e-mail addresses); this provides a total of 353,583 unique e-mail addresses for scientists. From the 
sample pool, we randomly selected two-thirds and sent out the survey invitations from May 4 to 17, 2020, except 
on Sundays. The number of survey invitations sent on each day were evenly distributed. A reminder e-mail was 
sent to invited participants who had not opened the survey link two weeks after the initial e-mail invitation. The 
survey was closed on June 3, 2020.
Of the 220,923 invitations sent (22,074 (9%) email addresses were invalid), 41.35% (91,346) were opened. 
The response rate based on e-mails opened was 13.93% (5.76% based on valid invitation), with 98% completed 
within 24 h upon opening the invitation link. The median response time was 16 min (M = 0.12 days, SD = 1.25). 
Our response rate is comparable to other studies with surveys sent to scientists through e-mail lists obtained 
from academic databases such as Scopus. For  example43 reported a 14.1% response rate from the online survey 
on public communication with 100,000+ faculty members from 73 land-grant  universities44; recorded a response 
rate of 12% in a web survey study exploring the consensus among scientists on the highly debated topic of cli-
mate change and environmental policy, using an email list composed from  Scopus45; reported a response rate of 
10.3% with a survey distributed to 729 authors via email and social networking  sites46; investigated the opinion 
of scientists on the peer review process from a list of academics at universities ranked highly at the Times Higher 
Education (THE) university rankings and obtained a response rate of about 5%. We also acknowledge the varia-
tion in the response rates across fields (see Supplementary Table 16), ranging from 8.19% (Health Professions) to 
19.47% (Economics). While our sample is large, self-selection remains one of the significant challenges in survey 
studies; for example, scholars in health science might be less inclined to respond due to increased workload 
during COVID-19.
The survey consisted of several sections on topics related to COVID-19, including a section devoted to 
opinions about immunity certificates. Questions pertaining to basic demographics were asked at the start of 
the survey. In addition, we asked our participants a series of control questions, including their political views, 
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religiosity, and marital status at the end of the survey. Participation in the survey was completely voluntary and 
subjects were able to skip any question they did not want to answer or quit the survey at any time. For this reason, 
there is a larger proportion of missing values on the control variables at the end of the survey (about 33%). To 
assess the reliability of the regression analysis (sensitivity to missing data), we report the results without these 
control variables (see Supplementary Information). Participants were self-selected from the pool of scientists 
mentioned above. Participants were told that the survey pertained to the COVID-19 health crisis, but they were 
not aware of the specific contents of each section before taking part in it. In order to incentivize the interest in 
the survey, the subjects were offered a $500 lottery for themselves and $500 for a charity of their choice upon 
leaving a contact email address in case they won the prize. Ethical clearance for the data collection was granted 
on April 23 by the Ethics Commission of the Frankfurt School of Finance and Management. All participants 
provided written informed consent at the outset of the survey, and all methods were performed in accordance 
with the relevant guidelines and regulations. Preliminary analysis on the difference in responses between health 
scientists and non-health scientists is provided  in47.
Sample description. Descriptive statistics of the sample are presented in Supplementary Table  17. We 
recorded a total of 12,738 responses from scientists across different disciplines. Females represent around 42% 
(n = 5335) of the sample, while 57% (n = 7218) of the participants are male. Most participants were in the age 
brackets 30 to 39 years old (32%, n = 4131) and 40 to 49 years old (29%, n = 3637). In addition, we recorded 
information of unique relevance to this demographic group, such as their field of study, how many of them have 
completed a PhD and whether they hold a professorship (28.5%, n = 3631). Most of the respondents are from 
Europe (42.3% n = 5408) and North America (37.22% n = 4759). The majority of participants held an assistant 
professorship (equivalent or below) (52.8% n = 6664).
Compared to economics scholars recruited from the top journals in the fields (n = 1440), the pool of sur-
vey participants drawn from the RePEc register (n = 1019) is composed of more males (5.3 percentage points, 
p = 0.004) and are from older age groups (p = 0.044 based on a two-tailed rank sum test). However, we did not 
find any significant discernible difference in other sample characteristics (e.g., professorship, political views, 
religiosity, marital status) between the two samples (all p > 0.1). Nevertheless, we control for this by including a 
dummy variable for participants from the RePEc sample in the regression analyses. While the sample from RePEc 
was more supportive of the immunity certificates in terms of inequality concerns (Supplementary Table 12) and 
have higher willingness to pay for the immunity certificates (Supplementary Table 13) than other economists and 
social scientists, removing the RePEc sample from the analysis does not change our qualitative and quantitative 
findings reported in the main text. The main results excluding the RePEc sample are reproduced in the Appendix 
SI (Supplementary Fig. 18 to 21 and Supplementary Table 18).
COVID-19 data. To control for contextual factors due to development of the COVID-19 pandemic, we col-
lected the daily confirmed case and case fatality rate (CFR) statistics at the country level, as well as a measure 
designed to capture the stringency level of government policy responses. COVID-19 statistics were obtained 
from the Center for Systems Science and Engineering (CSSE) at Johns Hopkins  University48 and the Stringency 
Index were obtained from the Oxford COVID-19 Government Response Tracker (OxCGRT))49. We add 1 to the 
daily number of COVID-19 confirmed case variable and implement a log transformation. The Stringency Index 
is the sum of eight containment and closure policy indicators together with the presence of public information 
campaigns  (see49 for details). The three cross-country daily measures were merged with the self-reported coun-
try of residency and survey submission date variables. These variables were included as controls in the regression 
models, together with country and time fixed effects.
Empirical approach. Appropriate statistical tests were chosen to perform the response comparisons 
between groups; both parametric and non-parametric tests were employed. Due to the ordinal nature of the 
response variables, we perform a non-parametric pairwise multiple  comparison50 and adjust the false discovery 
rate using the Benjamini–Hochberg stepwise adjustments. We also report the results of the Kruskal–Wallis rank 
test of the hypothesis that responses from different fields are from the same population. We employed both 
mean comparison t-test and the non-parametric Wilcoxon rank-sum for comparison between US and non-US 
responses. For US and non-US difference within fields, we implemented the Bonferroni correction to account 
for multiple comparison by inflating the significance cut-off by five-fold. To calculate the effect size for these 
comparisons, we follow the transformation of Cohen’s d for ordinal data proposed  by51, where d = 2*z/
√
n . Exact 
p-values (two-tailed) are reported. Statistical analyses were performed using Stata MP 16.1.
Consensus. To examine the degree of agreement among scientists, we closely follow the approach  of52,53 
when measuring consensus from variables with an ordinal scale. Consensus of the ordinal response variable X 








 , where p  is the share of 
responses (excluding non-responses). A value of 0 indicates the participants’ responses are evenly split to the two 
extremes, while a value of 1 means that all responses are in the same category. The consensus score is around 0.45 
(depending on the number of response categories) if responses are evenly split into each category. 95% confi-
dence intervals (error bars) of the consensus measure are constructed by performing bootstrap resampling with 
300 replications. We employ the two-sample t-test to test for statistically significant differences in the consensus 
scores between groups (across fields or US to non-US). Bonferroni adjustments were also used for multiple-field 
comparisons. Computing consensus using the Shannon Entropy equation, i.e., 1−
∑
pi×ln pi
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Ordered logit regressions. We employed the ordered logit regression model to examine the effect of sam-
ple characteristics and other factors on the response outcome. The ordered logit model is a more suitable model 
than the commonly used ordinary least squared (OLS) model as it recognizes that the response data is ordinal 
rather than interval. The ordered logit coefficient indicates the expected increase in the log odds of being in a 
higher level of the response variable, given a 1-unit increase in the predictor variable, holding other variables in 
the model constant. For ease of interpretation, we report the estimated proportional odds ratios (by exponentiat-
ing the coefficients), which can be interpreted as the odds for being in a higher level of the response variable (i.e., 
proportional odds times larger).
Data availability
All data analyzed in the current study are made available from Open Science Framework (https:// osf. io/ xghq7/). 
Data on selected journals are provided in the Supplementary Information.
Code availability
All computer code used in the data analysis is available from the corresponding author upon reasonable request.
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